Application no. and date | 11726579.3 (espacenet) (Federated) (European Patent Register), 20110603 | Patent/reg. no. and date | DK/EP 2575764, 20170419 | Publication date | 20130410 | Priority no. and date | US 351146 P, 20100603, US 201161489197 P, 20110523 | EP pub. no. and date |
EP 2575764 20130410 | Effective date | | Applicant/owner | Alnylam Pharmaceuticals, Inc., 300 Third Street
Cambridge, MA 02142, US | Applicant ref. no. | Alnylam Pharmaceuticals ALN-137EP_PO4590002528 | Inventor | AKINC, Akin, 300 Third Street
Cambridge, MA 02142, US, MANOHARAN, Muthiah, 300 Third Street
Cambridge, MA 02142, US, MAIER, Martin, 300 Third Street
Cambridge, MA 02142, US, JAYARAMAN, Muthusamy, 300 Third Street
Cambridge, MA 02142, US, MATSUDA, Shigeo, 300 Third Street
Cambridge, MA 02142, US, JAYAPRAKASH, Narayanannair, K., 300 Third Street
Cambridge, MA 02142, US, RAJEEV, Kallanthottathil, G., 300 Third Street
Cambridge, MA 02142, US, BAILLIE, Thomas, A., University of Washington, School of Pharmacy, Box 357631
Seattle, WA 98165-7631, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 31/713 (2006.01) , A61K 39/00 (2006.01) , A61K 47/44 (2017.01) , C07C 229/12 (2006.01) , C12N 15/113 (2010.01) , C12N 15/88 (2006.01) | Title | BIOLOGISK NEDBRYDELIGE LIPIDER TIL FREMFØRING AF AKTIVE MIDLER | Int. application no. | US2011039164 | Int. publication no. | WO2011153493 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|